日本ケミファの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/05/31 | 2,968 | 2,968 | 2,871 | 2,878 | +7 | +0.2% | 1,100 |
2019/05/30 | 2,877 | 2,900 | 2,861 | 2,871 | -43 | -1.5% | 1,000 |
2019/05/29 | 2,855 | 2,943 | 2,854 | 2,914 | +39 | +1.4% | 2,200 |
2019/05/28 | 2,995 | 2,995 | 2,852 | 2,875 | -120 | -4% | 1,000 |
2019/05/27 | 2,930 | 2,996 | 2,928 | 2,995 | +67 | +2.3% | 3,900 |
2019/05/24 | 2,949 | 2,949 | 2,892 | 2,928 | +7 | +0.2% | 1,800 |
2019/05/23 | 2,885 | 2,941 | 2,885 | 2,921 | +26 | +0.9% | 1,500 |
2019/05/22 | 2,995 | 2,995 | 2,891 | 2,895 | -105 | -3.5% | 1,400 |
2019/05/21 | 2,999 | 3,000 | 2,959 | 3,000 | +9 | +0.3% | 1,200 |
2019/05/20 | 2,975 | 3,015 | 2,975 | 2,991 | +16 | +0.5% | 2,500 |
2019/05/17 | 2,856 | 2,980 | 2,856 | 2,975 | +169 | +6% | 3,100 |
2019/05/16 | 2,859 | 2,860 | 2,806 | 2,806 | -49 | -1.7% | 3,100 |
2019/05/15 | 2,897 | 2,897 | 2,832 | 2,855 | -25 | -0.9% | 2,300 |
2019/05/14 | 2,865 | 2,890 | 2,860 | 2,880 | +11 | +0.4% | 4,100 |
2019/05/13 | 2,915 | 2,936 | 2,863 | 2,869 | +4 | +0.1% | 3,400 |
2019/05/10 | 2,879 | 2,879 | 2,855 | 2,865 | +15 | +0.5% | 3,300 |
2019/05/09 | 2,943 | 2,969 | 2,850 | 2,850 | -93 | -3.2% | 3,500 |
2019/05/08 | 2,946 | 2,981 | 2,910 | 2,943 | +47 | +1.6% | 5,600 |
2019/05/07 | 2,899 | 2,920 | 2,871 | 2,896 | -3 | -0.1% | 3,700 |
2019/04/26 | 2,873 | 2,917 | 2,873 | 2,899 | -7 | -0.2% | 2,900 |
2019/04/25 | 2,899 | 2,920 | 2,892 | 2,906 | +6 | +0.2% | 4,900 |
2019/04/24 | 2,856 | 2,905 | 2,856 | 2,900 | +7 | +0.2% | 2,400 |
2019/04/23 | 2,866 | 2,899 | 2,866 | 2,893 | +28 | +1% | 1,800 |
2019/04/22 | 2,896 | 2,896 | 2,860 | 2,865 | -7 | -0.2% | 1,600 |
2019/04/19 | 2,885 | 2,887 | 2,857 | 2,872 | +37 | +1.3% | 4,400 |
2019/04/18 | 2,900 | 2,900 | 2,830 | 2,835 | -65 | -2.2% | 3,600 |
2019/04/17 | 2,925 | 2,925 | 2,900 | 2,900 | -9 | -0.3% | 1,400 |
2019/04/16 | 2,930 | 2,940 | 2,909 | 2,909 | +5 | +0.2% | 800 |
2019/04/15 | 2,900 | 2,923 | 2,900 | 2,904 | +15 | +0.5% | 3,800 |
2019/04/12 | 2,875 | 2,889 | 2,875 | 2,889 | +15 | +0.5% | 1,600 |
2019/04/11 | 2,875 | 2,890 | 2,866 | 2,874 | +5 | +0.2% | 1,500 |
2019/04/10 | 2,857 | 2,874 | 2,857 | 2,869 | -25 | -0.9% | 4,400 |
2019/04/09 | 2,885 | 2,910 | 2,885 | 2,894 | +8 | +0.3% | 1,500 |
2019/04/08 | 2,910 | 2,939 | 2,886 | 2,886 | -20 | -0.7% | 3,400 |
2019/04/05 | 2,898 | 2,934 | 2,890 | 2,906 | +8 | +0.3% | 2,100 |
2019/04/04 | 2,901 | 2,917 | 2,896 | 2,898 | -19 | -0.7% | 3,300 |
2019/04/03 | 2,922 | 2,928 | 2,894 | 2,917 | -10 | -0.3% | 4,700 |
2019/04/02 | 2,971 | 2,971 | 2,906 | 2,927 | -44 | -1.5% | 3,600 |
2019/04/01 | 2,926 | 3,000 | 2,919 | 2,971 | +45 | +1.5% | 3,500 |
2019/03/29 | 2,896 | 2,944 | 2,896 | 2,926 | +30 | +1% | 1,700 |
2019/03/28 | 2,888 | 2,936 | 2,884 | 2,896 | -17 | -0.6% | 2,600 |
2019/03/27 | 2,977 | 2,977 | 2,913 | 2,913 | -52 | -1.8% | 3,400 |
2019/03/26 | 2,913 | 2,970 | 2,913 | 2,965 | +44 | +1.5% | 7,200 |
2019/03/25 | 2,957 | 2,957 | 2,898 | 2,921 | -49 | -1.6% | 3,300 |
2019/03/22 | 2,887 | 2,992 | 2,887 | 2,970 | +57 | +2% | 2,700 |
2019/03/20 | 2,995 | 2,995 | 2,911 | 2,913 | -42 | -1.4% | 1,700 |
2019/03/19 | 2,880 | 2,955 | 2,870 | 2,955 | +41 | +1.4% | 3,000 |
2019/03/18 | 2,815 | 3,070 | 2,815 | 2,914 | +105 | +3.7% | 10,500 |
2019/03/15 | 2,884 | 2,900 | 2,803 | 2,809 | +25 | +0.9% | 56,700 |
2019/03/14 | 2,880 | 2,880 | 2,783 | 2,784 | +4 | +0.1% | 3,000 |
1451~
1500
件表示中 / 3695件
類似銘柄と比較する
現在ご覧いただいている「日ケミファ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
日ケミファ | 153,000円 | +2.5% | - | 3.27% | 92.00倍 | 0.30倍 |
|
中堅後発薬メーカー。長期収載品の主力は痛風薬ウラリット。新薬開発、検査薬事業を中期強化 |
シンバイオ | 15,500円 | -24.2% | - | 0.00% | - | 1.95倍 |
|
導入で新薬開発・製品化。抗がん剤「トレアキシン」国内販売。抗ウイルス薬BCVの開発に注力 |
ソレイジア | 3,300円 | +311.4% | - | 0.00% | - | 6.23倍 |
|
がん柱の創薬ベンチャー。候補品導入後に開発進め権利再導出、製品販売を行うビジネスモデル |
OTS | 2,300円 | +63.9% | - | 0.00% | - | 6.85倍 |
|
がん治療ワクチン創薬ベンチャー。大手製薬と開発提携。東大医科研発。会社計画は非開示 |
ペルセウス | 42,700円 | +20.0% | - | 0.00% | - | 3.58倍 |
|
東大発バイオベンチャー。高機能抗体の取得に強み。抗体医薬品や抗体薬物複合体(ADC)開発 |
市場注目の銘柄
チャート関連のコラム